Cite
Biclonal IGHV-4-34 hairy cell leukemia variant and CLL - successful treatment with ibrutinib and venetoclax.
MLA
Jain, Preetesh, et al. “Biclonal IGHV-4-34 Hairy Cell Leukemia Variant and CLL - Successful Treatment with Ibrutinib and Venetoclax.” American Journal of Hematology, vol. 93, no. 12, Dec. 2018, pp. 1568–69. EBSCOhost, https://doi.org/10.1002/ajh.25264.
APA
Jain, P., Kanagal-Shamanna, R., Konoplev, S., Zuo, Z., & Estrov, Z. (2018). Biclonal IGHV-4-34 hairy cell leukemia variant and CLL - successful treatment with ibrutinib and venetoclax. American Journal of Hematology, 93(12), 1568–1569. https://doi.org/10.1002/ajh.25264
Chicago
Jain, Preetesh, Rashmi Kanagal-Shamanna, Sergej Konoplev, Zhuang Zuo, and Zeev Estrov. 2018. “Biclonal IGHV-4-34 Hairy Cell Leukemia Variant and CLL - Successful Treatment with Ibrutinib and Venetoclax.” American Journal of Hematology 93 (12): 1568–69. doi:10.1002/ajh.25264.